Studies have shown that NEK2 is involved in a variety of human cancers, including NSCLC 11, 12, myeloma 13, ovarian cancer 14, breast cancer 15, 16, prostate cancer 17, and colorectal cancer 18. This evidence concerns the gene NEK2 and non-small cell lung carcinoma.